journal cover

The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome

The New England Journal of Medicine

Jan 15, 1976

C T Richardson, J H Walsh

Abstract

Inhibition of acid secretion by an H2-receptor antagonist (metiamide) was assessed in three patients with the Zollinger-Ellison syndrome. Metiamide (200 or 300 mg) inhibited acid secretion transiently (2 1/2 hours) by 85 to 100 per cent in all patients. Although anticholinergic drugs al...read more

Mentioned in this Paper

Histamine Measurement
Propantheline
Metiamide Monohydrochloride
Antagonist Muscle Action
Polychemotherapy
Receptors, Drug
Anticholinergic [EPC]
Antihistamines, Classical
Drug Evaluation
Glycopyrrolate
Paper Details
References

The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome

The New England Journal of Medicine

Jan 15, 1976

C T Richardson, J H Walsh

PMID: 616

DOI: 10.1056/nejm197601152940304

Abstract

Inhibition of acid secretion by an H2-receptor antagonist (metiamide) was assessed in three patients with the Zollinger-Ellison syndrome. Metiamide (200 or 300 mg) inhibited acid secretion transiently (2 1/2 hours) by 85 to 100 per cent in all patients. Although anticholinergic drugs al...read more

Mentioned in this Paper

Histamine Measurement
Propantheline
Metiamide Monohydrochloride
Antagonist Muscle Action
Polychemotherapy
Receptors, Drug
Anticholinergic [EPC]
Antihistamines, Classical
Drug Evaluation
Glycopyrrolate
Paper Details
References
/papers/the-value-of-a-histamine-h2-receptor-antagonist/616